This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

7 May 2014

BMS Announces Retirement of Brian Daniels

Bristol-Myers Squibb Company has announced that Brian Daniels, senior vice president, Global Development and Medical Affairs, will be retiring from the company, effective 1 July 2014.


Dr Daniels joined Bristol-Myers Squibb in 2000 and has held his current position as senior vice president, Global Development and Medical Affairs since 2008, leading the development of numerous innovative medicines such as Eliquis and Yervoy that address serious diseases and communicating the value of these medicines to society to ensure their safe and appropriate use.


“Brian has played a key leadership role in the success of the company’s R&D organization and our ability to deliver innovative medicines to patients with serious diseases," said Francis Cuss, executive vice president and chief scientific officer, Bristol-Myers Squibb. "He has been a champion of the patients we serve, and I want to sincerely thank him for his loyalty and dedication to Bristol-Myers Squibb."

Related News